Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome. Diabetes 2013;62:1084–1093
In the article listed above, there are errors in Figures 3, 4, and 5, which show the effects of quercetin and apigenin in CD38 activity in vitro and in cells. The labels on the figures should read [Apigenin] and [Quercetin] and not Log [Apigenin] and Log [Quercetin] since the actual concentration is shown in the axis, and the scale already is log. These changes have no impact on the results or the conclusions of the study.
The online version reflects these changes.
- © 2014 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.